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INTRODUCTION
In the last decades growing evidence of a worldwide
increase in atopic diseases and sensitisation to common
allergenswas provided. Prevalence of asthma is increasing
most rapidly among children, especially where urbanisa-
tion takes place. Several risk factors that we can observe in
developing countries or in inner-city communities of the
developed countries contribute to asthma morbidity and
mortality. Poverty, climate, exposure to tobacco, viral
infection, outdoor air pollution and chemical irritants are
included in the most important risk factors (1).
The results of Phase 1 of the International Study on
Asthma and Allergic Diseases in Childhood (ISAAC) (2)
demonstrated that prevalence of childhood asthma from
most developing countries is similar to those observed in
developed regions. The different realities however deman-
ded for differentiated solutions on how to effectively and
efficiently provide comprehensive asthma health care
services. Moreover, asthma education and self manage-
ment must be increased in developed and developing
countries with different strategies because in many coun-
tries peoplewith commonChronical RespiratoryDiseases
(CRD) including asthma have no access to acceptable
standing of health care (3).
EPIDEMIOLOGICAL DATA
The results of Phase 1 of ISAAC indicate that the
prevalence of childhood asthma varies through the world
(4). The data from the 13/14 years old children studied in
155 centres from 56 countries in Europe, Asia, Oceanic,
Africa, Latin and North America, show that the highest
prevalence of asthma symptoms and severity in the last
12 months are in Australia and New Zealand (29,7%) and
the lowest in Asia (6,6%). The key finding of the ISAAC
Phase 1 is the wide variation in the prevalence symptoms
related to asthma with differences ranging 20 to 60-fold
between centres. The prevalence also varied according to
language, racial and ethnic characteristics or inheritance
as well as variation of environment and socio-economic
status.
In developing countries the risk of asthma related to
infection must be considered. Scrivener et al (5) showed
that the high degrees of parasite infections could prevent
asthma symptoms in atopic individuals in Ethiopia when
comparing populations from rural and urban areas. Addo
Yobo et al. (6) in Ghana demonstrated that the prevalence
of bronchospasm induced by exercise and atopy are higher
in rich urban areas than in poor or rural urban areas,
suggesting that in addition to genetic predisposition, social
and environmental factors are important determinants of
the phenotype. He also demonstrated that the sensitisation
to dust mite and cockroach allergens in inner-city popu-
lations were independent risk factors for asthma in
Ghanian children (7). Celedon et al. (8) refer a relationship
among markers of allergy, asthma, rhinitis and eczema in
Costa Rica similar with those found in countries with a
western lifestyle and different from those found in rural
areas of Africa and Asia. Brasilian studies present a strong
and statistically significant inverse association between
skin prick response to common aeroallergens and infec-
tion with Schistosoma mansoni (9).
Another study in day care centres and schools of Sa˜o
Paulo city (10), demonstrate that even these environments
play a significant role as sources of exposure to dust mites
and cockroach allergens and also endotoxin. In Hong
Kong (11) Leung conclude that the indoor aeroallergens
are one of the risk factors for the development and severity
of mild to moderate asthma in Chinese children.
The epidemiological data underline show the relevance
of the risk factors in different areas and the role of
protective factors as suggested by the hygiene hypothesis
in the developing countries (12).
DIAGNOSIS AND TREATMENT
Diagnosis of asthma in developing countries is not a
simple process. Social, financial, cultural and socio-
economical barriers as well as the organisation of national
health care systems in different countries make the task
very difficult.
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The diagnosis starts with specific training of profes-
sionals at different levels of the health care systemmaking
it possible to identify the symptoms and to develop
programs of prevention and treatment.
In what concerns treatment, GINA (13) and ARIA
(14) projects are world programs in this domain. However
the findings of these projects will have to be supported
by national guidelines according to national realities.
The cost of treatment should not be an obstruction to
access to the basic drugs (salbutamol, beclomethasone,
theophyline, prednisolone) in the middle and low-
income countries. In these countries the education of
patients play a relevant role and must be improved
to obtain a better collaboration in the administration of
drugs.
THE PORTUGUESE EXPERIENCE
Since 1989 an official protocol was started between the
Ministry of Health from Portugal and Cape Verde in
Allergology and Clinical Immunology under the coordi-
nation of the Immunoallergoloy Department of Dona
Estefaˆnia Hospital, Lisbon. Cape Verde Republic is since
1975 an independent country in Africa (Golf of Guinea)
with 434.812 inhabitants (2000 census) living in 9 islands;
infantile mortality rate 54/1000 new-borns; live expec-
tancy at birth 69,4 years; physicians 40/100.000 inhabi-
tants; GIP 4490 USD per capita. The Cape Verde Health
System includes 2 Central and 2 Regional Hospitals
(Hospital Network) and 17 sub-unit dependences and
basic sanitary units (Primary Care Systems). The pre-
valence of asthma in children is around 10% (15) and 5%
of the children were admitted in the emergency rooms in
2002. The available outpatient facilities are: emergency
room, treatment protocol, nebulizers and spacers in all the
Hospitals and sub-units dependences. Spirometry is avail-
able at the outpatient consultation in the 2 Central Hos-
pitals. The official collaboration between Portugal and
Cape Verde is made through direct activities (1 or 2 per
year) in the last 14 years involving physicians, health
technicians and psychologists and the main targets are:
a) clinical assistance and follow-up of the consultation
in the 2 Central Hospitals (more than 6.000 patients)
under the responsibility of two doctors trained by our
Department, implementation of guidelines for asthma
treatment and the offer of equipment (nebulizers, spacers
and spirometers) to the health care centres and the Central
Hospitals; b) educational activities - training of physicians
and health technicians in the respiratory area; c) research
projects - in the areas of epidemiology and laboratory
(15,16,17). In 2002 the first Allergologist Specialist from
Cape Verde concluded the training following a program
organised according with the national reality during
3 1/2 years under the supervision and responsibility of
our Department.
In the future the goals of the collaboration are: reduction
ofmortality andmorbidity, namely asthma related, impro-
ving better individual quality of life and self-management
programs in chronic respiratory diseases.
CONCLUSIONS
The prevention and treatment of asthma in developing
countriesmust be improved. The increasing of asthma and
allergic diseases in the last years in all the continents
demands for a global strategy including better surveil-
lance, prevention (primary, secondary and tertiary) and
access to a low price treatment. Strong partnerships
between health care national systems and other sectors
(governmental and nongovernmental organisations) in the
area of respiratory disease, as proposed by the World
Health Organization, are urgently needed to provide better
quality of life to these patients.
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